371 related articles for article (PubMed ID: 21914806)
1. Role of receptor for hyaluronic acid-mediated motility (RHAMM) in low molecular weight hyaluronan (LMWHA)-mediated fibrosarcoma cell adhesion.
Kouvidi K; Berdiaki A; Nikitovic D; Katonis P; Afratis N; Hascall VC; Karamanos NK; Tzanakakis GN
J Biol Chem; 2011 Nov; 286(44):38509-38520. PubMed ID: 21914806
[TBL] [Abstract][Full Text] [Related]
2. Receptor for hyaluronic acid- mediated motility (RHAMM) regulates HT1080 fibrosarcoma cell proliferation via a β-catenin/c-myc signaling axis.
Kouvidi K; Berdiaki A; Tzardi M; Karousou E; Passi A; Nikitovic D; Tzanakakis GN
Biochim Biophys Acta; 2016 Apr; 1860(4):814-24. PubMed ID: 26825774
[TBL] [Abstract][Full Text] [Related]
3. RHAMM/hyaluronan inhibit β-catenin degradation, enhance downstream signaling, and facilitate fibrosarcoma cell growth.
Berdiaki A; Thrapsanioti LN; Giatagana EM; K Karamanos N; C Savani R; N Tzanakakis G; Nikitovic D
Mol Biol Rep; 2023 Nov; 50(11):8937-8947. PubMed ID: 37710072
[TBL] [Abstract][Full Text] [Related]
4. The hyaluronan receptors CD44 and Rhamm (CD168) form complexes with ERK1,2 that sustain high basal motility in breast cancer cells.
Hamilton SR; Fard SF; Paiwand FF; Tolg C; Veiseh M; Wang C; McCarthy JB; Bissell MJ; Koropatnick J; Turley EA
J Biol Chem; 2007 Jun; 282(22):16667-80. PubMed ID: 17392272
[TBL] [Abstract][Full Text] [Related]
5. Oligosaccharides of hyaluronan induce angiogenesis through distinct CD44 and RHAMM-mediated signalling pathways involving Cdc2 and gamma-adducin.
Matou-Nasri S; Gaffney J; Kumar S; Slevin M
Int J Oncol; 2009 Oct; 35(4):761-73. PubMed ID: 19724912
[TBL] [Abstract][Full Text] [Related]
6. Hyaluronan stabilizes focal adhesions, filopodia, and the proliferative phenotype in esophageal squamous carcinoma cells.
Twarock S; Tammi MI; Savani RC; Fischer JW
J Biol Chem; 2010 Jul; 285(30):23276-84. PubMed ID: 20463012
[TBL] [Abstract][Full Text] [Related]
7. bFGF induces changes in hyaluronan synthase and hyaluronidase isoform expression and modulates the migration capacity of fibrosarcoma cells.
Berdiaki A; Nikitovic D; Tsatsakis A; Katonis P; Karamanos NK; Tzanakakis GN
Biochim Biophys Acta; 2009 Oct; 1790(10):1258-65. PubMed ID: 19577615
[TBL] [Abstract][Full Text] [Related]
8. Differences in hyaluronic acid-mediated functions and signaling in arterial, microvessel, and vein-derived human endothelial cells.
Lokeshwar VB; Selzer MG
J Biol Chem; 2000 Sep; 275(36):27641-9. PubMed ID: 10882722
[TBL] [Abstract][Full Text] [Related]
9. The roles of hyaluronan/RHAMM/CD44 and their respective interactions along the insidious pathways of fibrosarcoma progression.
Nikitovic D; Kouvidi K; Karamanos NK; Tzanakakis GN
Biomed Res Int; 2013; 2013():929531. PubMed ID: 24083250
[TBL] [Abstract][Full Text] [Related]
10. Hyaluronan induces vascular smooth muscle cell migration through RHAMM-mediated PI3K-dependent Rac activation.
Gouëffic Y; Guilluy C; Guérin P; Patra P; Pacaud P; Loirand G
Cardiovasc Res; 2006 Nov; 72(2):339-48. PubMed ID: 16934786
[TBL] [Abstract][Full Text] [Related]
11. Hyaluronan and the hyaluronan receptor RHAMM promote focal adhesion turnover and transient tyrosine kinase activity.
Hall CL; Wang C; Lange LA; Turley EA
J Cell Biol; 1994 Jul; 126(2):575-88. PubMed ID: 7518470
[TBL] [Abstract][Full Text] [Related]
12. A RHAMM mimetic peptide blocks hyaluronan signaling and reduces inflammation and fibrogenesis in excisional skin wounds.
Tolg C; Hamilton SR; Zalinska E; McCulloch L; Amin R; Akentieva N; Winnik F; Savani R; Bagli DJ; Luyt LG; Cowman MK; McCarthy JB; Turley EA
Am J Pathol; 2012 Oct; 181(4):1250-70. PubMed ID: 22889846
[TBL] [Abstract][Full Text] [Related]
13. Hyaluronan-dependent motility of B cells and leukemic plasma cells in blood, but not of bone marrow plasma cells, in multiple myeloma: alternate use of receptor for hyaluronan-mediated motility (RHAMM) and CD44.
Masellis-Smith A; Belch AR; Mant MJ; Turley EA; Pilarski LM
Blood; 1996 Mar; 87(5):1891-9. PubMed ID: 8634437
[TBL] [Abstract][Full Text] [Related]
14. Hyaluronate receptors mediating glioma cell migration and proliferation.
Akiyama Y; Jung S; Salhia B; Lee S; Hubbard S; Taylor M; Mainprize T; Akaishi K; van Furth W; Rutka JT
J Neurooncol; 2001 Jun; 53(2):115-27. PubMed ID: 11716065
[TBL] [Abstract][Full Text] [Related]
15. Potential role for hyaluronan and the hyaluronan receptor RHAMM in mobilization and trafficking of hematopoietic progenitor cells.
Pilarski LM; Pruski E; Wizniak J; Paine D; Seeberger K; Mant MJ; Brown CB; Belch AR
Blood; 1999 May; 93(9):2918-27. PubMed ID: 10216086
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of receptor for hyaluronan-mediated motility (RHAMM) in MC3T3-E1 cells induces proliferation and differentiation through phosphorylation of ERK1/2.
Hatano H; Shigeishi H; Kudo Y; Higashikawa K; Tobiume K; Takata T; Kamata N
J Bone Miner Metab; 2012 May; 30(3):293-303. PubMed ID: 21947782
[TBL] [Abstract][Full Text] [Related]
17. Rhamm-/- fibroblasts are defective in CD44-mediated ERK1,2 motogenic signaling, leading to defective skin wound repair.
Tolg C; Hamilton SR; Nakrieko KA; Kooshesh F; Walton P; McCarthy JB; Bissell MJ; Turley EA
J Cell Biol; 2006 Dec; 175(6):1017-28. PubMed ID: 17158951
[TBL] [Abstract][Full Text] [Related]
18. CD44-epidermal growth factor receptor interaction mediates hyaluronic acid-promoted cell motility by activating protein kinase C signaling involving Akt, Rac1, Phox, reactive oxygen species, focal adhesion kinase, and MMP-2.
Kim Y; Lee YS; Choe J; Lee H; Kim YM; Jeoung D
J Biol Chem; 2008 Aug; 283(33):22513-28. PubMed ID: 18577517
[TBL] [Abstract][Full Text] [Related]
19. Hyaluronic acid promotes angiogenesis by inducing RHAMM-TGFβ receptor interaction via CD44-PKCδ.
Park D; Kim Y; Kim H; Kim K; Lee YS; Choe J; Hahn JH; Lee H; Jeon J; Choi C; Kim YM; Jeoung D
Mol Cells; 2012 Jun; 33(6):563-74. PubMed ID: 22610405
[TBL] [Abstract][Full Text] [Related]
20. Co-localization and crosstalk between CD44 and RHAMM depend on hyaluronan presentation.
Carvalho AM; Soares da Costa D; Paulo PMR; Reis RL; Pashkuleva I
Acta Biomater; 2021 Jan; 119():114-124. PubMed ID: 33091625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
